ABBV-CLS-484, an Orally Bioavailable, Dual PTPN1/PTPN2 Phosphatase Inhibitor with Antitumor Activity

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2024; 20(01): 0089
DOI: 10.1055/s-0043-1763633

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nicholas A. Meanwell (Baruch S. Blumberg Institute, U. Michigan)

phosphatase inhibitor - phosphate isostere - immunomodulatory - anti-tumor agent

Article published online:
08 December 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany